First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice

The role of adherence in virological suppression in patients receiving anti-HBV analogues

(2011) Philippe Sogni et al.   ANTIVIRAL THERAPY

Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B

(2011) Nghiem B. Ha et al.   DIGESTIVE DISEASES AND SCIENCES

Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma

(2011) Chuen–Fei Chen et al.   GASTROENTEROLOGY

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

(2011) Roeland Zoutendijk et al.   HEPATOLOGY

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

(2011) Yun-Fan Liaw et al.   HEPATOLOGY

Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice

(2011) E. Ridruejo et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Natural history of chronic hepatitis B REVEALed

(2011) Chien-Jen Chen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

748 OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B

(2011) W.-K. Seto et al.   JOURNAL OF HEPATOLOGY

Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B

(2011) Stefan Mauss et al.   JOURNAL OF HEPATOLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

(2010) Yun-Fan Liaw et al.   HEPATOLOGY

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

(2010) Andrea Snow-Lampart et al.   HEPATOLOGY

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

1016 LOW RATES OF NUCLEOS(T)IDE-ASSOCIATED ADVERSE EVENTS IN THE LONG-TERM EXPERIENCE WITH ENTECAVIR

(2010) M. Manns et al.   JOURNAL OF HEPATOLOGY

Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B

(2010) Andrés Duarte-Rojo et al.   Therapeutic Advances in Gastroenterology

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

(2009) Christian M. Lange et al.   HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

20 ENTECAVIR MAINTAINS A HIGH GENETIC BARRIER TO HBV RESISTANCE THROUGH 6 YEARS IN NAIVE PATIENTS

(2009) D.J. Tenney et al.   JOURNAL OF HEPATOLOGY

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis

(2009) Ju Hyun Shim et al.   JOURNAL OF HEPATOLOGY

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

(2008) Yun-Fan Liaw et al.   Hepatology International

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE